Expression of CD103 facilitates localization and activation of CD4+ T cells within Mycobacterium tuberculosis lung-lesions
The spatial localization of CD4<sup>+</sup> T cells within the Mycobacterium tuberculosis (Mtb)-infected lung is critical for optimal immunity. Here, we investigate the role of two E-cadherin binding receptors, CD103 and KLRG1. We demonstrate that KLRG1 restricts CD4<sup>+</sup> T cells to the lung vasculature early during infection, and limits lesion homing at chronic stages. Subunit vaccination diminishes KLRG1 expression and increases CD103<sup>+</sup> CD4<sup>+</sup> T cells associated with improved bacterial control. We identify a link between CD103 expression and Th17 differentiation, as vaccine-induced Th17 cells display increased propensity to upregulate CD103 in the lung. Mixed bone marrow chimeras reveal that CD103 promotes tissue retention and localization of CD4<sup>+</sup> T cells in close proximity to Mtb, facilitating enhanced TCR signaling. In contrast, CD103-deficient cells remain confined to the lesion periphery with decreased TCR activation. These findings highlight the importance of CD103 in CD4<sup>+</sup> T cell localization and antigen-sensing with implications for vaccine design.
Authors
- Nafsika Panagiotopoulou (ORCID: https://orcid.org/0000-0003-4082-4218)
- Sylvia M. Stull (ORCID: https://orcid.org/0000-0002-9999-1531)
- Anders Woetmann (ORCID: https://orcid.org/0000-0002-3008-735X)
- Benjamin H. Gern (ORCID: https://orcid.org/0000-0002-0142-5970)
- Rasmus J. Mortensen (ORCID: https://orcid.org/0000-0003-0177-3032)
- Tu Hu (ORCID: https://orcid.org/0000-0002-4635-4117)
- Mehnaz Halima (ORCID: https://orcid.org/0000-0001-8632-7589)
- Sara Cohen
- Mari Morikawa
- Peter L. Andersen
- Paula Fernández Rodríguez
- Camilla Myhre Maymann
- Kevin B. Urdahl
- Thomas Lindenstrøm
- Joshua S. Woodworth
Institutions
- Statens Serum Institut (DK)
- University of Geneva (CH)
- University of Copenhagen (DK)
- Center for Infectious Disease Research (US)
- Infectious Disease Research Institute (US)
- Novo Nordisk (Denmark) (DK)
- Novo Nordisk Foundation (DK)
- LEO Foundation (DK)
Publication Details
- Journal
- Mucosal Immunology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.mucimm.2026.02.001
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00